X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs MYLAN (US) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   MYLAN
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
MYLAN
Dec-14
ALEMBIC LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs724,115-   
Low Rs342,900-   
Sales per share (Unadj.) Rs4.71,408.6-  
Earnings per share (Unadj.) Rs6.1169.7-  
Cash flow per share (Unadj.) Rs6.2273.2-  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.7700.2-  
Shares outstanding (eoy) m267.03378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x11.32.5 452.4%   
Avg P/E ratio x8.720.7 42.0%  
P/CF ratio (eoy) x8.512.8 66.0%  
Price / Book Value ratio x1.35.0 26.0%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1391,327,031 1.1%   
No. of employees `000NA25.0 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM21,319.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,568.3-  
INCOME DATA
Net Sales Rs m1,255532,989 0.2%  
Other income Rs m370-3,107 -11.9%   
Total revenues Rs m1,625529,882 0.3%   
Gross profit Rs m111132,557 0.1%  
Depreciation Rs m3839,146 0.1%   
Interest Rs m222,990 0.0%   
Profit before tax Rs m44267,314 0.7%   
Minority Interest Rs m0-276 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m242,831 0.8%   
Profit after tax Rs m1,63064,207 2.5%  
Gross profit margin %8.924.9 35.6%  
Effective tax rate %5.44.2 128.9%   
Net profit margin %129.812.0 1,077.9%  
BALANCE SHEET DATA
Current assets Rs m1,867468,568 0.4%   
Current liabilities Rs m591366,326 0.2%   
Net working cap to sales %101.619.2 529.9%  
Current ratio x3.21.3 246.9%  
Inventory Days Days9478 120.7%  
Debtors Days Days74107 68.6%  
Net fixed assets Rs m1,791123,305 1.5%   
Share capital Rs m53418,848 2.8%   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,858264,948 4.1%   
Long term debt Rs m41395,806 0.0%   
Total assets Rs m11,5911,067,186 1.1%  
Interest coverage x260.93.9 6,641.7%   
Debt to equity ratio x01.5 0.3%  
Sales to assets ratio x0.10.5 21.7%   
Return on assets %14.18.2 172.3%  
Return on equity %15.024.2 61.9%  
Return on capital %15.213.6 111.5%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m23670,062 0.3%  
From Investments Rs m-224-55,253 0.4%  
From Financial Activity Rs m-27-18,461 0.1%  
Net Cashflow Rs m-15-3,652 0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.04 Rs / USD

Compare ALEMBIC LTD With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALEMBIC LTD With: SANOFI INDIA  DISHMAN PHARMA  ALKEM LABORATORIES  FULFORD INDIA  NATCO PHARMA  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Mar 22, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS